| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_621f0ea7dc150d921dbc4265f5fa1ab8 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-252
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-252
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7052
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7042
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7034
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7028
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-048 |
| filingDate |
1995-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_68b10084f258ae2d9721cf23ac7b741c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d45421366803208fe44f4b69c7126c1e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14c1cfdaf77ac45d7b20b1a7e5b3e0df
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cfab2d7fd4f0096ff88209651a55c43a |
| publicationDate |
1996-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-H08231581-A |
| titleOfInvention |
Anthracycline derivative |
| abstract |
(57) Abstract: An object is to obtain a novel anthracycline analog having high antitumor activity. An anthracycline analog compound of the following formula A or a pharmaceutically acceptable salt thereof. This compound is particularly useful as an antineoplastic agent in the treatment of leukemia or colon adenocarcinoma. Embedded image |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2003531821-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2022518842-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011516507-A |
| priorityDate |
1994-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |